BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32240523)

  • 1.
    Lang A; Kumar A; Jirschitzka J; Bordusa F; Ohlenschläger O; Wiedemann C
    Biomol NMR Assign; 2020 Oct; 14(2):163-168. PubMed ID: 32240523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia.
    Tanner SM; Austin JL; Leone G; Rush LJ; Plass C; Heinonen K; Mrózek K; Sill H; Knuutila S; Kolitz JE; Archer KJ; Caligiuri MA; Bloomfield CD; de La Chapelle A
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13901-6. PubMed ID: 11707601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAALC, a novel marker of human hematopoietic progenitor cells.
    Baldus CD; Tanner SM; Kusewitt DF; Liyanarachchi S; Choi C; Caligiuri MA; Bloomfield CD; de la Chapelle A
    Exp Hematol; 2003 Nov; 31(11):1051-6. PubMed ID: 14585369
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lang A; Goradia N; Wikman H; Werner S; Wilmanns M; Ohlenschläger O
    Biomol NMR Assign; 2020 Oct; 14(2):271-275. PubMed ID: 32557393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baalc, a marker of mesoderm and muscle.
    Satoskar AA; Tanner SM; Weinstein M; Qualman SJ; de la Chapelle A
    Gene Expr Patterns; 2005 Apr; 5(4):463-73. PubMed ID: 15749074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L
    Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Easy and unambiguous sequential assignments of intrinsically disordered proteins by correlating the backbone 15N or 13C' chemical shifts of multiple contiguous residues in highly resolved 3D spectra.
    Yoshimura Y; Kulminskaya NV; Mulder FA
    J Biomol NMR; 2015 Feb; 61(2):109-21. PubMed ID: 25577242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
    Eisfeld AK; Marcucci G; Liyanarachchi S; Döhner K; Schwind S; Maharry K; Leffel B; Döhner H; Radmacher MD; Bloomfield CD; Tanner SM; de la Chapelle A
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6668-73. PubMed ID: 22493267
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Górka M; Żerko S; Konrat R; Koźmiński W; Kurzbach D
    Biomol NMR Assign; 2020 Oct; 14(2):289-293. PubMed ID: 32583165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis.
    Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L
    Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kumar A; Wißbrock A; Bellstedt P; Lang A; Ramachandran R; Wiedemann C; Imhof D; Ohlenschläger O
    Biomol NMR Assign; 2019 Apr; 13(1):155-161. PubMed ID: 30758717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
    Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
    Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells.
    Xu B; Chen G; Shi P; Guo X; Xiao P; Wang W; Zhou S
    Hematology; 2012 Jan; 17(1):35-40. PubMed ID: 22549446
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Thapa CJ; Haataja T; Pentikäinen U; Permi P
    Biomol NMR Assign; 2020 Oct; 14(2):227-231. PubMed ID: 32468417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia.
    Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH
    Leuk Lymphoma; 2014 Jan; 55(1):110-20. PubMed ID: 23647058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of combined BAALC and MN1 gene expression level in acute myeloid leukemia with normal karyotype.
    Marjanovic I; Karan-Djurasevic T; Kostic T; Virijevic M; Vukovic NS; Pavlovic S; Tosic N
    Int J Lab Hematol; 2021 Jun; 43(3):433-440. PubMed ID: 33242229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia.
    Hasan SK; Patkar NV; Rajamanickam D; Gokarn A; Lucena-Araujo AR; Tembhare P; Bagal B; Kadam Amare P; Jain H; Gujral S; Sengar M; Subramanian PG; Khattry N
    Hematol Oncol; 2020 Dec; 38(5):808-816. PubMed ID: 32893896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the
    Xiao SJ; Shen JZ; Huang JL; Fu HY
    Mol Clin Oncol; 2015 Jul; 3(4):880-888. PubMed ID: 26171200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.